Singapore markets closed
Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,497.75 +10.72 (+0.20%) Dow
38,910.07 +75.21 (+0.19%) Nasdaq
17,896.11 +33.88 (+0.19%) Bitcoin USD
64,832.19 -131.92 (-0.20%) CMC Crypto 200
1,347.75 -34.92 (-2.52%)
Innate Pharma S.A. (0EVI.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
As of 11:27AM BST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 168.78M |
| Enterprise value | 116.22M |
| Trailing P/E | 13.89 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.21 |
| Price/book (mrq) | 3.23 |
| Enterprise value/revenue | 2.24 |
| Enterprise value/EBITDA | -7.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.60 |
| 52-week change 3 | -31.91% |
| S&P500 52-week change 3 | 25.22% |
| 52-week high 3 | 3.0712 |
| 52-week low 3 | 1.9640 |
| 50-day moving average 3 | 2.3333 |
| 200-day moving average 3 | 2.3654 |
Share statistics
| Avg vol (3-month) 3 | 839 |
| Avg vol (10-day) 3 | 679 |
| Shares outstanding 5 | 80.63M |
| Implied shares outstanding 6 | 80.63M |
| Float 8 | 30.31M |
| % held by insiders 1 | 24.80% |
| % held by institutions 1 | 9.78% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | -119.90% |
| Operating margin (ttm) | -48.42% |
Management effectiveness
| Return on assets (ttm) | -6.60% |
| Return on equity (ttm) | -71.91% |
Income statement
| Revenue (ttm) | 52.28M |
| Revenue per share (ttm) | 0.65 |
| Quarterly revenue growth (yoy) | -11.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -19.19M |
| Net income avi to common (ttm) | -62.63M |
| Diluted EPS (ttm) | -0.7800 |
| Quarterly earnings growth (yoy) | -72.70% |
Balance sheet
| Total cash (mrq) | 88.89M |
| Total cash per share (mrq) | 1.1 |
| Total debt (mrq) | 40.66M |
| Total debt/equity (mrq) | 70.27% |
| Current ratio (mrq) | 3.84 |
| Book value per share (mrq) | 0.72 |
Cash flow statement
| Operating cash flow (ttm) | -31.84M |
| Levered free cash flow (ttm) | -25.52M |
© 2024 Yahoo. All rights reserved.